1604-77-9

Basic information

• Product Name: 8-chloro-7-(2-chlorobenzyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
• Synonyms: 8-chloro-7-(2-chlorobenzyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
• CAS NO: 1604-77-9
• Molecular Formula: C₁₄H₁₂Cl₂N₄O₂
• Molecular Weight: 339.17668
• Mol File: 1604-77-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 8-chloro-7-(2-chlorobenzyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 8-chloro-7-(2-chlorobenzyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione(1604-77-9)
• EPA Substance Registry System: 8-chloro-7-(2-chlorobenzyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione(1604-77-9)

Safety Data

• Hazardous Substances Data: 1604-77-9(Hazardous Substances Data)

Upstream product

• 611-19-8 1-chloro-2-(chloromethyl)benzene 

Downstream Products

• 485821-43-0 8-(3-Amino-azepan-1-yl)-7-(2-chloro-benzyl)-1,3-dimethyl-3,7-dihydro-purine-2,6-dione 
• 485821-44-1 8-(3-aminoazepan-1-yl)-1,3-dimethyl-7-(2-chlorobenzyl)-3,7-dihydropurine-2,6-dione trifluoroacetate 

Relevant articles and documents

SUCCINATE SALTS OF HETEROCYCLIC DPP-IV INHIBITORS

The present invention relates to therapeutically active and selective hemisuccinate salts of inhibitors of the enzyme DPP-IV of formula (I), pharmaceutical compositions comprising the salts and the use of such salts for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.

Hetrocyclic compounds that are inhibitors of the enzyme DPP-IV

The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are